Page 2 - Les meilleurs doctors traitant la maladie suivante : Métaplasie gastrique - TOP -58 des médecins

Spécialisé dans les cancers gastro-intestinaux avec un accent sur le traitement du cancer de l'estomac, y compris la métaplasie gastrique, au sein des hôpitaux Valued Med Hub.

• Plus de 10 ans d'expérience en oncologie médicale
• Recherches publiées sur le cancer gastrique métastatique HER2-positif
• Membre de l'Association Turque d'Oncologie Médicale
• Contributeur à des études sur les facteurs prédictifs dans le traitement du cancer gastrique

Spécialisé dans la chirurgie abdominale ouverte et mini-invasive, y compris la procédure complexe de Whipple. Il dirige le département de chirurgie colorectale du centre médical Sourasky (Ichilov).

• Plus de 20 ans d'expérience en chirurgie
• Expert en techniques mini-invasives avancées
• Chef de service, à la tête d'une équipe chirurgicale spécialisée

Le Dr Yildiz possède une vaste expérience de recherche sur les tumeurs neuroendocrines gastro-entéro-pancréatiques, avec des publications dans Medical Oncology et d'autres revues de renom.

• Se spécialiser dans les tumeurs neuroendocrines et les pathologies associées
• Publier plusieurs études sur la synthèse des stéroïdes et le diabète
• Rechercher des cas rares tels que le pemphigus paranéoplasique
• Travailler à l'Hôpital Universitaire Medipol Mega

Un oncologue autrichien de premier plan, spécialisé dans la thérapie systémique et personnalisée. Le Pr Köstler apporte plus de 20 ans d'expertise en soins cancérologiques à la Wiener Privatklinik.

• Autorité internationale en matière de traitements ciblés et d'immunothérapie
• Spécialisé dans les cancers du sein et gynécologiques
• Consultant senior et ancien chef adjoint de l'oncologie à l'Université de médecine de Vienne
• Professeur associé dédié à la recherche sur les biomarqueurs et la biologie tumorale

Le professeur Gul Alco apporte plus de 25 ans d'expérience spécialisée en radio-oncologie dans les institutions de premier plan en Turquie, telles que l'hôpital de district Medipol Acibadem.

• Formé à l'université d'Istanbul – l'une des meilleures facultés de médecine de Turquie
• Actuel professeur de radio-oncologie à l'université Medipol d'Istanbul
• Expérience en tant que professeur associé à l'université Demiroglu Bilim
• Spécialisé dans les radiothérapies gastro-intestinales

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le Dr Alemdar est spécialisé dans la métaplasie gastrique, avec une solide formation académique à l'Université d'Akdeniz.

• Certifié en médecine interne et en oncologie médicale
• Des années d'expérience hospitalière, notamment au centre hospitalier universitaire d'Akdeniz
• Expert dans la gestion des pathologies gastro-intestinales complexes
• Être actif dans la recherche et la formation au sein des hôpitaux universitaires

En tant que chef du centre d'oncologie gastro-intestinale, le Dr Hubert dirige une unité spécialisée dans les cancers digestifs complexes.

• 33 ans d'expérience clinique en oncologie et radiothérapie
• Double certification de spécialiste en oncologie et en radiothérapie
• Médecin senior à l'hôpital universitaire Hadassah
• Membre actif du comité israélien pour le cancer gastro-intestinal
• Formation comprenant à la fois un doctorat en médecine et un diplôme en psychologie

Spécialisée en virothérapie – l'un des domaines les plus récents de l'immunologie – le Dr Jaunalksne apporte des approches innovantes à la Clinique Pallas.

• Plus de 30 ans d'expérience en immunologie
• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne

Le Dr Al est spécialisé en chirurgie laparoscopique pour les pathologies gastriques, formé aux facultés Çapa et Cerrahpaşa de l'Université d'Istanbul.

• Certifié avec plus de 30 ans d'expérience chirurgicale
• Formation avancée en chirurgie bariatrique et oncologique laparoscopique
• Fellowship en techniques de chirurgie laparoscopique antireflux
• Pratiquer des procédures mini-invasives pour une récupération plus rapide

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Spécialisé dans le cancer gastrique et les pathologies associées, avec une vaste expertise chirurgicale aux hôpitaux Büyük Anadolu.

• Expérimenté dans les chirurgies du pancréas et des voies biliaires
• Réaliser des chirurgies bariatriques et métaboliques
• Qualifié en chirurgie oncologique et mammaire